Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Faslodex (fulvestrant) for the Treatment of Advanced Breast Cancer

Drug (Brand/Generic)

Faslodex/fulvestrant

Company/Licensee

AstraZeneca

Therapy Class

Oestrogen receptor antagonist

Current Indication

Advanced breast cancer

Market Sector

Oncology

Development Status

Approved in the US and Europe
Expand

Go Top